Comparative analysis of neuroinflammatory pathways in Alzheimer's disease, Parkinson's disease, and multiple sclerosis: insights into similarities and distinctions
- PMID: 40364858
- PMCID: PMC12069400
- DOI: 10.3389/fnins.2025.1579511
Comparative analysis of neuroinflammatory pathways in Alzheimer's disease, Parkinson's disease, and multiple sclerosis: insights into similarities and distinctions
Abstract
Neurodegenerative diseases, contributing to the significant socioeconomic burden due to aging society, are gaining increasing interest. Despite each disease having different etiologies, neuroinflammation is believed to play a crucial role in Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS). In addition to the pathogenic function of inflammation in the brain there is growing evidence that immune responses are essential for neuroregeneration. This review compares and contrasts the neuroinflammatory pathways that selected neurodegenerative diseases share and have in common. In AD, tau tangles and beta-amyloid plaques cause microglia and astrocytes to become activated in an inflammatory response. Alpha-synuclein aggregation stimulate neuroinflammation in Parkinson's disease, especially in the substantia nigra. In Multiple Sclerosis an autoimmune attack on myelin is connected to inflammation via invading immune cells. Commonalities include the release of pro-inflammatory mediators like cytokines and activation of signaling pathways such as NF-κB and MAPK. Comprehending these common routes is essential for discovering early diagnostic possibilities for the diseases and possible tailored treatments. Our work underscores the potential for insights into disease mechanisms. Identifying common targets offers promise for advancing our understanding and potential future treatment approaches across these debilitating disorders.
Keywords: Alzheimer’s disease; Parkinson’s disease; multiple Sclerosis; neurodegeneration; neuroinflammation.
Copyright © 2025 Doroszkiewicz, Winkel and Mroczko.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Modulation of Inflammatory Mediators and Microglial Activation Through Physical Exercise in Alzheimer's and Parkinson's Diseases.Neurochem Res. 2022 Nov;47(11):3221-3240. doi: 10.1007/s11064-022-03713-x. Epub 2022 Aug 13. Neurochem Res. 2022. PMID: 35962936 Review.
-
The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma.Front Aging Neurosci. 2017 Jul 6;9:214. doi: 10.3389/fnagi.2017.00214. eCollection 2017. Front Aging Neurosci. 2017. PMID: 28729832 Free PMC article. Review.
-
Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration.Front Cell Neurosci. 2017 Jul 24;11:216. doi: 10.3389/fncel.2017.00216. eCollection 2017. Front Cell Neurosci. 2017. PMID: 28790893 Free PMC article. Review.
-
Neuroinflammation in Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics.Inflammation. 2023 Feb;46(1):1-17. doi: 10.1007/s10753-022-01721-1. Epub 2022 Aug 20. Inflammation. 2023. PMID: 35986874 Review.
-
Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.Eur J Med Chem. 2019 May 1;169:185-199. doi: 10.1016/j.ejmech.2019.03.009. Epub 2019 Mar 8. Eur J Med Chem. 2019. PMID: 30877973 Review.
Cited by
-
A Transcriptomic Roadmap of Parkinson's Disease Progression at Single Cell Resolution.medRxiv [Preprint]. 2025 Jul 30:2025.07.30.25332436. doi: 10.1101/2025.07.30.25332436. medRxiv. 2025. PMID: 40766144 Free PMC article. Preprint.
-
Association between non-motor symptoms of Parkinson disease and serum lipid levels: Analysis and clinical significance.Medicine (Baltimore). 2025 Aug 8;104(32):e43494. doi: 10.1097/MD.0000000000043494. Medicine (Baltimore). 2025. PMID: 40797497 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources